Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H24N2O2.2C7H9N3O4S |
| Molecular Weight | 666.768 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@@H](CO)NCCN[C@@H](CC)CO.OS(=O)(=O)CNNC(=O)C1=CC=NC=C1.OS(=O)(=O)CNNC(=O)C2=CC=NC=C2
InChI
InChIKey=UZLDZDGQEWRBAL-BZDVOYDHSA-N
InChI=1S/C10H24N2O2.2C7H9N3O4S/c1-3-9(7-13)11-5-6-12-10(4-2)8-14;2*11-7(6-1-3-8-4-2-6)10-9-5-15(12,13)14/h9-14H,3-8H2,1-2H3;2*1-4,9H,5H2,(H,10,11)(H,12,13,14)/t9-,10-;;/m0../s1
| Molecular Formula | C10H24N2O2 |
| Molecular Weight | 204.3098 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | C7H9N3O4S |
| Molecular Weight | 231.229 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/7265605Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/3582057 | https://www.google.com/patents/DE2036935C3 | https://www.ncbi.nlm.nih.gov/pubmed/24543417
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7265605
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/3582057 | https://www.google.com/patents/DE2036935C3 | https://www.ncbi.nlm.nih.gov/pubmed/24543417
Isobutol (trade name ISOETAM) is a salt of ethambutol and isoniazid methanesulfonate with tuberculostatic and bacteriostatic action. The purpose of this combination is to keep the strong anti-microbic activity of isoniazid in the manner where ethambutol would delay the appearance of resistance.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL1849 Sources: http://www.ncbi.nlm.nih.gov/pubmed/14623976 |
0.75 nM [Ki] | ||
Target ID: CHEMBL1877 Sources: http://www.drugbank.ca/drugs/DB00330 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | ISOETAM Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7265605
Dose was 11 mg per kilogram body weight or one tablet per 10 kilograms body weight given in two divided doses, after meals.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:49:58 GMT 2025
by
admin
on
Mon Mar 31 20:49:58 GMT 2025
|
| Record UNII |
EFA3DCV6KG
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m5045
Created by
admin on Mon Mar 31 20:49:58 GMT 2025 , Edited by admin on Mon Mar 31 20:49:58 GMT 2025
|
PRIMARY | Merck Index | ||
|
90478660
Created by
admin on Mon Mar 31 20:49:58 GMT 2025 , Edited by admin on Mon Mar 31 20:49:58 GMT 2025
|
PRIMARY | |||
|
EFA3DCV6KG
Created by
admin on Mon Mar 31 20:49:58 GMT 2025 , Edited by admin on Mon Mar 31 20:49:58 GMT 2025
|
PRIMARY | |||
|
41663-50-7
Created by
admin on Mon Mar 31 20:49:58 GMT 2025 , Edited by admin on Mon Mar 31 20:49:58 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |